1-20 of 39 results for subject:"Medical equipment"
Librarians' tools
- Search time
- 0.228 seconds
- Solr query time
- 0.005 seconds
- Search query
- subject:"Medical equipment"
- We searched for
- subject_t:"Medical equipment" OR subject_t:"Medical devices" OR subject_ses:91970
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what recent assessment his Department made of the potential barriers that prevent disabled people from accessing lifesaving medical equipment.
To ask the Secretary of State for Health and Social Care, what recent assessment his Department made of the potential barriers that prevent disabled people from accessing lifesaving medical equipment.
Integrated care boards (ICBs) are responsible for commissioning services to meet the health needs of their local population, and responsibility for providing medical equipment to disabled people typically falls to the National Health Service and local authorities.
We expect ICBs to follow guidance from the National Institute for Health and Care Excellence (NICE). In 2022, NICE published relevant guidance in relation to children, which is available at the following link:
Local authorities in England have a statutory duty, including under the Care Act 2014, to make arrangements for the provision of disability aids and community equipment to meet the assessed eligible needs of individuals who are resident in their area. Responsibility for managing the market for these services, including commissioning and oversight of delivery, rests with local authorities.
More broadly, the Government wants disabled people’s access to, and experience of, healthcare services to be equitable, effective, and responsive to their needs. Our 10-Year Health Plan for England sets out to tackle health inequalities, and specifically identifies disabled people as a priority group for neighbourhood health teams, which will offer more holistic on-going support.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41044 on Radiotherapy: Medical Equipment, whether there is funding remaining for hospital trusts wishing to submit late applications for radiotherapy equipment.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41044 on Radiotherapy: Medical Equipment, whether there is funding remaining for hospital trusts wishing to submit late applications for radiotherapy equipment.
The bidding round has been completed and there are no plans to accept further applications.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 April 2025 to Question 47191 on Radiotherapy: Medical Equipment, if he will ensure that trusts outside of (a) London and (b) the South East are prioritised for future funding (i) to replace radiotherapy...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 28 April 2025 to Question 47191 on Radiotherapy: Medical Equipment, if he will ensure that trusts outside of (a) London and (b) the South East are prioritised for future funding (i) to replace radiotherapy...
NHS England wrote to all radiotherapy treatment providers, including those outside of London and the South East, inviting them to apply for funding to replace ageing radiotherapy machines.
To help to address accessibility to radiotherapy, the Department has allocated £70 million in funding for 28 new radiotherapy machines to trusts across the country to replace outdated machines, 18 of which are located outside of London and the South East of England.
All future spending commitments beyond 2025/26 will be determined through the next phase of the Spending Review process, which will conclude in June.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41043 on Radiotherapy: Medical Equipment, what his Department's process of advertising the funding applications to NHS foundation trusts was.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41043 on Radiotherapy: Medical Equipment, what his Department's process of advertising the funding applications to NHS foundation trusts was.
In December 2024, NHS England wrote to all radiotherapy treatment providers inviting them to apply for funding to replace ageing radiotherapy machines.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41043, what the criteria was for these funding awards to NHS foundation trusts.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41043, what the criteria was for these funding awards to NHS foundation trusts.
Funding was allocated to trusts using criteria that NHS England developed. These criteria focused on the age of the machine being replaced, the proportion of older machines in use within the trust, and the trust’s performance on radiotherapy.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41044, what was the criteria for the award of this funding to NHS foundation trusts.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 April 2025 to Question 41044, what was the criteria for the award of this funding to NHS foundation trusts.
In 2024/25, we prioritised funding for a small number of trusts to replace the most aged radiotherapy equipment. Funding was allocated based on the age of the equipment to be replaced, replacement machine availability, and the trust’s ability to take delivery and pay for the equipment by 31 March 25.
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the availability of non-invasive cancer treatment technologies in the NHS.
To ask the Secretary of State for Health and Social Care, what steps he is taking to increase the availability of non-invasive cancer treatment technologies in the NHS.
Data on the number of cancer patients that have had access to minimally invasive cancer therapies in the last year by integrated care board (ICB), is not collected. The adoption of new treatments, including increasing the number and availability of minimally invasive cancer treatments, into the National Health Service in England is generally the result of National Institute for Health and Care Excellence (NICE) guidance and commissioner decisions. Both NHS England and the ICBs are required to put access in place for any treatment that carries a positive recommendation from the Technology Appraisal programme, operated by the NICE.
Where treatments are approved by the NICE through the Technology Appraisals programme, the NHS is required to make them available within agreed timescales, which vary by technology. Implementation of any NICE approvals will be supported by the service readiness assessment, and the development of additional capacity where necessary.
During 2024/25, NHS England will continue to support all ICBs in integrating the planning and commissioning of suitable specialised services with their wider population-level commissioning responsibilities, in line with their individual timeline for delegation. All systems are asked to make progress in transforming pathways of care in their priority areas.
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the National Equipment Tracking and Inventory System highlights radiotherapy cancer treatment machines that are over 10 years old; and if he will ensure that sufficient capital funding is available to replace...
To ask the Secretary of State for Health and Social Care, if he will take steps to ensure that the National Equipment Tracking and Inventory System highlights radiotherapy cancer treatment machines that are over 10 years old; and if he will ensure that sufficient capital funding is available to replace...
The Department can confirm that the National Equipment Tracking and Inventory System highlights radiotherapy cancer treatment machines within the National Health Service, as well as their associated ages.
Since April 2022 the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the NHS for 2022 to 2025, and the latest Capital Planning Guidance.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that radiotherapy LINAC machines used in NHS Trusts are replaced once they go beyond their recommended 10-year lifespan; and what assessment he has made of the potential merits of rolling replacement...
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that radiotherapy LINAC machines used in NHS Trusts are replaced once they go beyond their recommended 10-year lifespan; and what assessment he has made of the potential merits of rolling replacement...
Since April 2022, the responsibility for investing in new radiotherapy machines has sat with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service from 2022 to 2025.
Recent capital planning guidance sets out the expectation that the majority of radiotherapy equipment, particularly linear accelerator machines, will need to be replaced at 10 years of age, to make progress on NHS Long Term Plan priorities. The guidance states that integrated care systems need to develop replacement plans as part of their multi-year capital plans, in partnership with specialised commissioners, Cancer Alliances and Radiotherapy Operational Delivery Networks, based on an assessment of equipment age, capacity and demand, opportunities to improve access and service risk.
To ask the Secretary of State for Health and Social Care, whether the Major Conditions and Diseases Strategy will include plans to increase (a) access to radiotherapy cancer treatments, (b) the number of radiotherapy treatment machines and (c) the specialist radiotherapy cancer workforce.
To ask the Secretary of State for Health and Social Care, whether the Major Conditions and Diseases Strategy will include plans to increase (a) access to radiotherapy cancer treatments, (b) the number of radiotherapy treatment machines and (c) the specialist radiotherapy cancer workforce.
The Government cannot pre-empt the Major Conditions Strategy prior to its publication.
The Major Conditions Strategy will look at the treatment and prevention of cancer in people of all ages, covering the patient pathway. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for cancer patients.
This Strategy will draw on previous work on cancer, including over 5,000 submissions provided to the Department as part of our Call for Evidence last year. We will continue to work closely with stakeholders, citizens, and the National Health Service in coming weeks to identify actions for the Strategy that will have the most impact.
To ask the Secretary of State for Health and Social Care, how many radiotherapy LINAC machines will be over the 10 year recommended age by the end of (a) 2023, (b) 2024 and (c) 2025.
To ask the Secretary of State for Health and Social Care, how many radiotherapy LINAC machines will be over the 10 year recommended age by the end of (a) 2023, (b) 2024 and (c) 2025.
The information requested is not held centrally.
To ask the Secretary of State for Health and Social Care, how much was spent from the public purse on radiotherapy equipment and software in (a) 2019-20, (b) 2020-21 and (c) 2021-22; and whether the Government plans to increase that funding in future years.
To ask the Secretary of State for Health and Social Care, how much was spent from the public purse on radiotherapy equipment and software in (a) 2019-20, (b) 2020-21 and (c) 2021-22; and whether the Government plans to increase that funding in future years.
The total central investment made between 2016 and 2021 was £162 million and enabled the replacement or upgrade of circa 100 radiotherapy treatment machines.
From April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service, and the recent Capital Planning Guidance, which states that integrated care systems (ICSs) will need to develop replacement plans as part of their multi-year capital plans, in partnership with specialised commissioners, Cancer Alliances and Radiotherapy Operational Delivery Networks, based on an assessment of equipment age, capacity and demand, opportunities to improve access and service risk.
To ask the Secretary of State for Health and Social Care, what data his Department holds on the number of EGC heart monitors available to patients in the North Easington Primary Care Network as of 1 March 2023.
To ask the Secretary of State for Health and Social Care, what data his Department holds on the number of EGC heart monitors available to patients in the North Easington Primary Care Network as of 1 March 2023.
The information requested is not held centrally.
To ask the Secretary of State for Health and Social Care, what the average waiting time was to receive an EGC heart monitor assessment for patients in the North Easington Primary Care Network as of 1 March 2023.
To ask the Secretary of State for Health and Social Care, what the average waiting time was to receive an EGC heart monitor assessment for patients in the North Easington Primary Care Network as of 1 March 2023.
The information requested is not held centrally.
Motion that this House has considered access to radiotherapy. Agreed to on question.
Motion that this House has considered access to radiotherapy. Agreed to on question.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 October 2020 to Question 92759 and with reference to the Spending Review 2020, what funding will be allocated for the replacement of NHS linear accelerator radiotherapy machines.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 October 2020 to Question 92759 and with reference to the Spending Review 2020, what funding will be allocated for the replacement of NHS linear accelerator radiotherapy machines.
Following the outcome of Spending Round 2020, spending plans for individual budgets in 2021-22 will be subject to a detailed financial planning exercise and finalised in due course.
To ask the Secretary of State for Health and Social Care, whether a proportion of the Spending Review 2020 commitments of (a) £1.5 billion allocated to ease existing pressures in the NHS caused by the covid-19 outbreak and (b) £559 million to support the modernisation of technology across the health...
To ask the Secretary of State for Health and Social Care, whether a proportion of the Spending Review 2020 commitments of (a) £1.5 billion allocated to ease existing pressures in the NHS caused by the covid-19 outbreak and (b) £559 million to support the modernisation of technology across the health...
Following the outcome of Spending Round 2020, spending plans for individual budgets in 2021-22 will be subject to a detailed financial planning exercise and finalised in due course.
To ask the Secretary of State for Health and Social Care, what the funding allocations for the replacement of NHS linear accelerator radiotherapy machines (a) was for the financial year 2019-20 and (b) is for the financial year (i) 2021-22 and (ii) 2022-23.
To ask the Secretary of State for Health and Social Care, what the funding allocations for the replacement of NHS linear accelerator radiotherapy machines (a) was for the financial year 2019-20 and (b) is for the financial year (i) 2021-22 and (ii) 2022-23.
Future National Health Service capital funding will be determined as part of the Department’s multi-year settlement at the next Spending Review.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 51867 on Radiotherapy: Medical Equipment, for what reason he did not provide the data requested on the estimated number of patients expected to receive proton beam therapy at (a)...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 51867 on Radiotherapy: Medical Equipment, for what reason he did not provide the data requested on the estimated number of patients expected to receive proton beam therapy at (a)...
The Christie NHS Foundation Trust Proton Beam Therapy (PBT) Centre treated 160 patients with PBT in its first year of operation (December 2018 – December 2019).
University College London Hospital PBT Centre has a similar ramp up plan, and it is anticipated will treat a similar number of patients in its first year of operation.
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 51866 on Radiotherapy: Medical Equipment, for what reason he did not provide the data requested on the estimated cost to the public purse of purchasing and installing proton beam...
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 51866 on Radiotherapy: Medical Equipment, for what reason he did not provide the data requested on the estimated cost to the public purse of purchasing and installing proton beam...
The Government has invested £250 million in the development of the two PBT centres at The Christie Hospital in Manchester and University College London Hospital. This included construction of the centres and the purchase and installation of the equipment.